Lion Rock Minerals Ltd (ASX: LRM) Lion Rock Minerals Limited (ASX: LRM), formerly Peak Minerals Limited, is an Australian-listed mineral sands and critical minerals explorer focused on the development of its flagship Minta Rutile & Monazite Project in central Cameroon. The Company holds an 80% group interest in 18 granted exploration permits and three further permits under valid application across approximately 8,800 km² of prospective ground at Minta, with approximately 5,000 km² described as the higher-priority prospective belt within that footprint. Beyond Minta, Lion Rock holds the Kitongo and Lolo Uranium Projects in Cameroon (six tenements totalling approximately 2,440 km², all currently pending grant) and the Yendon Kaolin Project in Victoria (four licences in the Ballarat-Bendigo zone of the Lachlan Fold Belt). The Green Rocks Project in Western Australia was divested in April 2026 as non-core. Read More

Samso is an independent research media house producing depth-led video and written content on ASX-listed companies. We exist to create the research that helps listed businesses brand their story to investors who want to understand what matters. Healthcare Renewable Energy Media & Technology Industrial & Business Services Healthcare Financial Services Metals and Mining Investor interviews and briefings with industry leaders from the healthcare, well being and fitnes sectors. Investment Thoughts Ceretas IPO: A portable ultrasound headset for Alzheimer's lines up for the ASX Brisbane biotech Ceretas is seeking $8 million to take a decade of University of Queensland brain research from the lab bench to the clinic. Noel Ong Jul 27 8 min read AI and Dementia: How Artificial Intelligence Is Changing Diagnosis, Care and Early Detection Dementia is one of those global health issues that quietly grows in the background until it becomes impossible to ignore. It does not carry the drama of a sudden outbreak or the headlines of a breakthrough cancer drug, but its impact is profound. It affects memory, judgement, independence and identity. Noel Ong Apr 24 9 min read Echo IQ – Mayo Clinic Agreement Expands Commercial Pathway for EchoSolv HF After FDA Clearance Echo IQ Ltd (ASX: EIQ) has expanded its agreement with Mayo Clinic to enable the potential resale and distribution of its heart failure decision support solution, EchoSolv HF, following FDA clearance. I have liked the Echo IQ story from the first time I was introduced to it. The business is operating in a space where clinical validation, regulatory approval, and commercial deployment must align before revenue can be realised. Noel Ong Mar 26 6 min read Control Bionics Expands Speech-Generating Devices in the United States archTIS Limited (ASX: AR9) operates in a specialised segment of the cybersecurity market focused on data-centric security for government, defence, and regulated industries. The Company’s positioning within Zero Trust architecture and attribute-based access control (ABAC) environments places it in a sector where procurement cycles are long and compliance standards are strict. Noel Ong Mar 6 7 min read Emyria Limited – Two-Thirds of PTSD Patients in Remission 12+ Months Post Treatment - Investors Take Note. The business of metal health is banking on this growing concern in the general population. The statistics for the general population in regards to some form of depression are staggering and I would bet that there would be easily be only one of two separation before you know someone needing help. Noel Ong Feb 23 7 min read Control Bionics Limited — U.S. Pilot Distribution Agreement with Tobii Dynavox Control Bionics Limited (ASX: CBL) has announced a new agreement with Tobii Dynavox, a global leader in Augmentative and Alternative Communication (AAC), to evaluate a potential U.S. distribution partnership for its NeuroNode® technology. The agreement initiates a six-month pilot program across five north-western U.S. states, positioning NeuroNode alongside Tobii Dynavox’s established communication aids. Noel Ong Feb 13 5 min read Actinogen Medical Limited — $4.3m Non-Dilutive Funding Secured to Extend Alzheimer’s Trial Runway. Actinogen Medical Limited (ASX: ACW) is progressing its lead drug candidate, Xanamem (emestedastat), through the XanaMIA Phase 2b/3 Alzheimer’s disease clinical trial being conducted across Australia and the United States. The Company is developing Xanamem as a once-daily oral therapy targeting cortisol regulation in the brain, to slow disease progression in patients with mild to moderate Alzheimer’s disease. Noel Ong Feb 12 4 min read Echo IQ Limited — FDA 510(k) Submission Lodged Following Mayo Clinic Validation - Catalyst for Market Acceptance ? - Time to get On Board the EIQ Train Echo IQ Limited (ASX: EIQ) is an Australian AI and medical technology company focused on improving decision-making in cardiology. Its lead product, EchoSolv HF, is a heart failure clinical decision support software designed to assist clinicians in detecting heart failure using echocardiogram data. The Company’s recent announcements outline the completion of clinical validation with the Mayo Clinic Platform and the subsequent formal lodgement of an FDA 510(k) submission in the Noel Ong Jan 30 7 min read Proteomics International — Canadian Patent Granted for PromarkerEso - A Precision Diagnostics Business - Market Penetration Proteomics International (ASX: PIQ) is a precision diagnostics company focused on the development and commercial launch of first-in-class blood-based diagnostic tests targeting diseases that are often detected late and are costly to manage. The Company operates a platform-based model, combining proprietary biomarkers, validated clinical data, accredited laboratories, and a digital sales pathway to support direct sales and future licensing across multiple tests and jurisdictio Noel Ong Jan 30 5 min read Singular Health Group – USD $1.3m U.S. Commercial Contract with PNS Signals First National-Scale Rollout – Healthcare Image Interoperability and Scalable SaaS Revenue Samso is drawn to Singular Health because it is transitioning from proof-of-concept into contracted commercial deployment within the U.S. healthcare system. The Company is addressing a clearly defined inefficiency—medical imaging interoperability—through a regulatory-cleared, enterprise-ready platform with early validation from a large MSO partner. Noel Ong Jan 28 7 min read Vitrafy Life Sciences — IMV Strategic Commercial Agreement Marks a Commercial Validation Step - A Definite #SamsoDYOR and a strong consideration for position play. Vitrafy Life Sciences Limited (ASX: VFY) released a market update on 15 January 2026 outlining a strategic commercial agreement with global animal reproduction leader IMV Technologies. The agreement positions Vitrafy’s cryopreservation technology within IMV’s global product and distribution platform, marking a material step in Vitrafy’s commercial execution strategy following Samso’s earlier IPO coverage of the Company. Noel Ong Jan 28 7 min read Samso News: NeuroScientific Biopharmaceuticals Limited – StemSmart™ Delivers Clinical Responses in Fistulising Crohn’s Disease – Time for understaing when to take your position. Samso is drawn to NeuroScientific because the Company is transitioning from early-stage development into real-world clinical validation. The Special Access Program outcomes represent a tangible inflection point, where clinical efficacy, regulatory engagement, and manufacturing readiness begin to converge around a scalable therapeutic platform. Noel Ong Jan 23 8 min read Samso News: ReNerve Limited — A Peripheral Nerve Injury Story – Too Early To Take A Position? ReNerve Limited has secured market registration approval in Malaysia for its NervAlign® Nerve Cuff, marking another regulatory milestone in the Company’s Asia-Pacific expansion strategy. The approval adds to existing clearances in Hong Kong and Thailand and follows a positive assessment of ReNerve’s clinical evaluation data. With an established US commercial base and a growing portfolio of nerve repair and tissue products. Noel Ong Jan 21 7 min read Island Pharmaceuticals Strengthens Galidesivir Position with New US Filoviridae Patent - An Antiviral Solution for your Watchlist. Island Pharmaceuticals Limited (ASX: ILA) is advancing its antiviral strategy through the clinical development of Galidesivir, a broad-spectrum antiviral targeting high-consequence viral threats, including Marburg and Ebola. The program is positioned within a global biosecurity and public health framework, with regulatory engagement centred on the United States Food and Drug Administration (FDA) and potential inclusion in government stockpiles. Noel Ong Jan 20 7 min read BCAL Diagnostics Limited Expands Early Cancer Detection with National Avantect Rollout - Research To Commercial Early Cancer Diagnostics - SamsoDYOR. BCAL Diagnostics is transitioning from a long-standing research-led organisation into a commercial early cancer diagnostics company, with laboratory operations based in Sydney and expanding national reach across Australia. The Company’s FY25 AGM and its 9 December 2025 ASX announcement collectively outline a business now focused on scaling commercial adoption following the launch of its first diagnostic product and the upcoming national rollout of additional early-detection t Noel Ong Jan 15 7 min read 1 2 3 4 5

OD6 Metals Limited (ASX:OD6) OD6 Metals Limited (ASX:OD6) is an Australian public company pursuing exploration and development opportunities within the critical minerals sector within Australian and the U.S. The Company has successfully identified clay hosted rare earths at its 100% owned Splinter Rock, located in the Esperance-Goldfields region of Western Australia – about 150km northeast of the major port and town of Esperance. OD6 Metals has recently secured an option to acquire the Quinn Fluorspar Project in Neveda, USA. In 1969, the United States Geological Survey (USGS) conducted a survey and confirmed fluorspar grading up to 72% CaF2 in bulk samples. The company is advancing the historic high grade Copper-Zinc Gulf Creek Mine in NSW. The copper-zinc mineralisation is connected with magnetite which shows repeat structures to the north and west of the mine with >10km of untested strike. Read More

Iron Bear Resources Ltd (ASX: IBR) Iron Bear Resources Ltd (ASX: IBR), formerly Cyclone Metals Limited, is an Australian-listed exploration and development company focused on large-scale iron ore assets. The company’s core asset is the Iron Bear Project in the Labrador Trough, Canada. This is a globally recognised iron ore region with established infrastructure and long mining history. The project sits near rail and port access, which is critical for bulk export. Iron Bear is advancing a magnetite iron ore development with potential to produce both blast furnace and direct reduction (DR) grade products. This aligns with the shift toward lower-emission steelmaking. Beyond iron ore, the company retains exposure to other commodities including gold, copper, lithium, and nickel, providing broader upside across the portfolio. Read More

Subscribe to Samso and download eBooks on How to Add Value to Your Share Portfolio. You will receive "lessons" on understanding each industry, their trends, strategic intent and reports that guide you to making mindful decisions on your share investments. Samso's eBooks Download Samso's eBook series on How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Subscribe Download Samso's eBook First Name Last Name Email I want to subscribe to the newsletter. Submit to Download

Samso Insights is your Gateway to Unparalleled Business Intelligence! Samso Insights is your backstage pass to a comprehensive understanding of cutting-edge industry knowledge and advancements across diverse business sectors. 🌟 As a privileged member of Samso Insights, you can embark on a thrilling journey where the heartbeat of the business world resonates with unparalleled intensity! Latest Samso stories and insights. Don't miss a beat. Remember to subscribe. Free Subscriptions The Calcium Curse — why a tungsten skarn fights back at the mill Roughly half the world's tungsten lives in skarn: a hard, ugly, calc-silicate rock that forms where a hot granite leans against limestone. Strip away the market noise and this is a story about chemistry at a contact. Here is how it works — in pictures. 21 hours ago What Is a Token in AI? The Jargon of AI Explained for Investors A token is a small piece of a word, and AI bills everything in tokens. Part 1 of The Language of AI decodes the industry’s jargon for investors in plain English. 3 days ago Reading the Skarn — where tungsten hides in the contact Roughly half the world's tungsten lives in skarn: a hard, ugly, calc-silicate rock that forms where a hot granite leans against limestone. Strip away the market noise and this is a story about chemistry at a contact. Here is how it works — in pictures. 3 days ago How to Buy the AI Build-Out on the ASX — semiconductors, data centres, and the vector-database gap Where an ASX investor can actually buy the AI build-out: semiconductor and data-centre stocks explained, plus why there's no ASX vector-database play. Jul 30 The Paradox: The Price Fell, The Bill Rose - AI Agent Economics AI's inputs got over 99% cheaper, yet AI bills keep rising. A plain-English guide to agentic AI economics, and the one cost test investors should apply to any AI story. Jul 26 Who Got the Chance — why investors mistake timing, visibility and luck for talent - Equity Investment Myths Timing, visibility, funding and luck decide more investing outcomes than talent. Part 1 of a Samso series on the human behaviours behind our decisions. Jul 25 The Dilemma of Investing in the Iron Ore Story The iron ore market is splitting in two. The product that pays today's dividends, 62% Fe fines (62% iron content) into Chinese blast furnaces, carries a softening price outlook on every published forecast. The product with the strongest structural story, high-purity magnetite feed for direct-reduction steelmaking, sits mostly in projects that are the hardest to finance. That is the dilemma. Jul 23 Twelve on the Watchlist: value left behind in the gold price correction? The gold price has fallen roughly 28% from its January 2026 record high, and the share prices of small gold companies have fallen even harder. This Insight walks through twelve ASX-listed gold small-caps, one by one, in plain language. For each company we ask two simple questions. Does the project stack up as a real, money-making mine? And does the company look like the kind of business a bigger gold miner would want to buy? Jul 19 The Handback: What Rio Tinto's Kasiya exit says and doesn't say about titanium and graphite On 8 July 2026, Rio Tinto told Sovereign Metals it will not exercise its option to become operator of the Kasiya rutile-graphite project in Malawi, handing back full control of one of the largest critical-minerals discoveries of the decade. Read one way, that looks like a vote of no confidence from the world's second-largest miner. Jul 12 The Big Consolidation — where the gold price settles before its next move Start with the facts as of this week. Spot gold is trading around US$4,025–4,050 per ounce (2 July 2026), having touched an eight-month low earlier in the week before recovering above US$4,000. That is roughly 28% below the record high of ~US$5,595–5,602 set on 28–29 January 2026 — and yet still about 22% higher than a year ago. Both of those numbers matter, and most commentary quotes only one of them. Jul 8 Copper's precious passengers — where platinum and palladium hide in a porphyry A handful of the world's giant copper mines also carry platinum and palladium. They are rarely worth mining on their own — but the story of how they got there is one of the clearest windows we have into how a copper-gold deposit is made. This is that story, told for the curious rather than the credentialled. Jul 5 The Gold Question— Which Way Form Here Gold has corrected hard from a January 2026 record near US$5,589 to about US$4,200 by mid-June, yet almost every major bank still points higher over a 12-month view. The disagreement is about how high and by what road — and for ASX investors, the AUD gold price (near record) matters more than the USD headline. Jun 21 1 2 3 4 5 "The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints." - Read full disclaimer . Join Samso Insights for Unmatched Investment Opportunities All investors can subscribe to a free version of our Samso Insights. For the bold and dedicated investor, give your investment journey a competitive advantage with a monthly subscription that takes you further by providing timely information and updates from important companies that are making a difference. You can also opt to access only select articles based on your unique investment needs. Get Free Alerts To Samso Insights Support Samso What do you get as a Samso Member? Samso Insights is your backstage pass to a comprehensive understanding of cutting-edge industry knowledge and advancements across diverse business sectors. As a privileged member of Samso Insights, you can embark on a thrilling journey where the heartbeat of the business world resonates with unparalleled intensity! Dive into a world of exclusive access, where the pulse of timely information and updates throbs at your fingertips. Gain an electrifying competitive advantage for your investments with insights that transcend the ordinary. Immerse yourself in the wisdom of esteemed CEOs and influential thought leaders who shape the very fabric of industries. They're not just sharing insights; they're unveiling the secrets to success, unraveling the mysteries of commodities, and predicting market trends that can redefine your financial destiny! This is not just another investment information platform; it's a high-octane community meticulously crafted for the trailblazers, the visionaries, and the dedicated investors hungry for more. Seize the opportunity to actively engage with the powerhouses poised to make a seismic impact. It's not just an information resource; it's a front-row seat to the future, where you can learn alongside the key companies destined for greatness. Don't miss the chance to turn insights into action, trends into triumphs, and curiosity into cash flow! 🚀 Join Samso Insights today – because success favours the bold, and the boldest investors choose Samso. 💼💰 Sign up as a Member now

Samso Australia is committed to ensuring your personal information is professionally managed. Our privacy policy is to provide information to you on how your personal information is collected and used within Samso Australia, and the circumstances in which we share it with third parties. Privacy Policy Samso Australia | Privacy Policy 25 June 2020 Samso Australia is a digital relations services company. Samso's core service "Coffee With Samso " includes a set of industrial leader conversations so that your ASX company brand can be more visible to investors. Samso Australia is committed to ensuring your personal information is professionally managed in accordance with all Australian Privacy Principles (APPs). This privacy policy is to provide information to you on how your personal information is collected and used within Samso Australia, and the circumstances in which we share it with third parties. What personal information we collect and why Samso Australia handles all personal data in accordance with applicable personal data laws. When a user completes an online form for subscriptions or for free download of material that we share on the Samso Australia website, such customer or user consents to the processing of their personal data by Samso Australia in accordance with the purpose for which the data was provided. The information we collect and hold generally includes: Name, company, address and contact details. Data from customer surveys, subscriptions or newsletters. Data from Samso social media and other digital platforms. How we use your personal information We use the information we collect for the purpose disclosed at the time of collection or otherwise as set out in this Privacy Policy. We will not use your personal information for any other purpose without first seeking your consent, unless authorised or required by law. Generally we will only use your personal information: To maintain your relationship as a customer of Samso Australia To provide the services you have requested from Samso Australia To take payments in exchange for a product or service To book our calendar To administer and manage those services To detect, prevent and address technical issues To answer your inquiry For marketing of services you have shown interest in and only with your explicit prior consent Agents and third party software Samso Australia may use from time to time agents, social media and/or other cloud based software to market and/or manage our business, example, WIX or MailChimp etc who may collect your details on our behalf. You may also refer to their relevant privacy policies for more information. Retention of data Samso Australia will retain your Personal Data only for as long as is necessary for the purposes set out in this Privacy Policy. We will retain and use your Personal Data to the extent necessary to comply with our legal obligations (for example, if we are required to retain your data to comply with applicable laws), resolve disputes, and enforce our legal agreements and policies. Samso Australia will also retain Usage Data for internal analysis purposes. Usage Data is generally retained for a shorter period of time, except when this data is used to strengthen the security or to improve the functionality of our Service, or we are legally obligated to retain this data for longer time periods. Personal data You may at any time decline any further marketing communications. You may also at any time ask to be removed from our mailing list. Customers have the following rights in respect of their personal data: Access to personal information and request a copy of such information, subject to law. Request correction and updating of personal data. Demand the deletion of personal data, subject to law. Withdraw a consent to process personal data, subject to law. We reserve the right to reject any requests in respect of processing personal data which are of a harassing or repetitive nature, which require disproportionate technical measures, which impact the protection of other customers’ personal data, or where it would be disproportionately resource-demanding or highly complicated to accommodate the request. We protect personal data from unauthorised disclosure. Only Samso Australia persons/employees who require access to the personal data in connection with their job function have access to this data. In some cases, Samso Australia may be required by law or by the order of a public authority to transfer personal data. Cookies and information collected - Deidentified Our website uses cookies. Cookies are used for personal settings, website functionality and targeted marketing. In your browser, you can delete cookies, or set the browser to request your permission to accept cookies. When you access our website, there is a record of your visit made in the web server logs of the following information for statistical purposes: Your source IP address Your domain or top-level domain name (for example .com, .gov, .au etc) The date and time of your visit to the site The pages you accessed and documents downloaded (if any) The type of browser you are using Your age, gender, and interests based on other websites you have visited. As far as we know, Google Analytics does not collect information about sensitive interests such as race, religion, sexual orientation, health, or financial status. This non-identified information is used by us to monitor usage patterns on our sites in order to improve navigation and design features. We do not provide any of this information to third parties. We also use Google Analytics to track website usage and more can be found about this product on the Google Analytics information pages . You can control the age, gender, and interests information, or opt-out of having this information collected through Google. Dealing with us anonymously You have the right to deal with us anonymously or under a pseudonym, unless it is impracticable for us to do so or unless we are requested or authorised by law to only deal with identified individuals. Changes to this privacy policy It may be necessary for us to review and revise our Privacy Policy from time to time. An amended version will be posted on our website at www.samso.com.au If you have any questions, please do not hesitate to contact us. Contact Us Dsiclaimer

Echo IQ Limited (ASX: EIQ) Echo IQ Limited (ASX: EIQ) is an Australian-based medical technology company focused on artificial intelligence solutions for cardiac diagnostics. The company’s core product is EchoSolv, an AI-driven decision support tool designed to assist clinicians in detecting structural heart disease using echocardiography. The technology aims to reduce misdiagnosis and improve clinical workflow efficiency. Echo IQ has achieved key regulatory milestones, including FDA clearance in the United States. The company is progressing commercialisation through strategic partnerships, including its collaboration with the Mayo Clinic. Echo IQ is positioning itself within the growing digital health and AI diagnostics sector, targeting improved patient outcomes and more efficient healthcare delivery. Read More

Samso is an independent research media house producing depth-led video and written content on ASX-listed companies. We exist to create the research that helps listed businesses brand their story to investors who want to understand what matters. Renewable Energy Media & Technology Media & Technology Industrial & Business Services Healthcare Financial Services Metals and Mining Investor interviews and briefings with industry leaders from the media and technology sectors. Investment Thoughts What Is a Token in AI? The Jargon of AI Explained for Investors A token is a small piece of a word, and AI bills everything in tokens. Part 1 of The Language of AI decodes the industry’s jargon for investors in plain English. Noel Ong 3 days ago 17 min read How to Buy the AI Build-Out on the ASX — semiconductors, data centres, and the vector-database gap Where an ASX investor can actually buy the AI build-out: semiconductor and data-centre stocks explained, plus why there's no ASX vector-database play. Noel Ong Jul 30 12 min read The Paradox: The Price Fell, The Bill Rose - AI Agent Economics AI's inputs got over 99% cheaper, yet AI bills keep rising. A plain-English guide to agentic AI economics, and the one cost test investors should apply to any AI story. Noel Ong Jul 26 9 min read Monvia Ltd (ASX: MNV) IPO: Life insurance software veteran lists on the ASX with a $17.5 million raise Monvia is behind the core systems of some of Australia's largest life insurers hit the boards at midday, priced at $1.10 a share and valued at approximately $103.5 million at the offer price. Noel Ong Jul 24 9 min read Echo IQ: A Fully Funded, FDA-Cleared Cardiac-AI Company Scaling EchoSolv into the US Discover how Echo IQ, a leading cardiac-AI company, is advancing in the US market with its FDA-cleared EchoSolv technology. Explore Echo IQ's innovations now! Noel Ong Jul 10 12 min read When the Smartest AI Model Is Worth the Least At SuperAI 2026, a European lab, a Chinese lab, and a veteran investor agreed the AI frontier has quietly moved — away from topping benchmarks, toward owning deployment, distribution, and the ground beneath the tokens.A panel discussion, moderated by Zixuan Li (Head, Z.ai), with:Geoff Soon, Mistral AI · Cherie Shi, MiniMax · Hemant Mohapatra, LightspeedSuperAI 2026 · Marina Bay Sands, Singapore · 10 June 2026For a few years, the word frontier had a simple meaning in artificia Noel Ong Jul 6 11 min read When the Web Learned to Lie: AI Agents A radio hoax fooled millions in 1938. Nearly ninety years later, the things being fooled aren't human — and the web is quietly feeding them poison. Adapted from a talk by Ariel Shulman, Chief Product Officer, Bright Data SuperAI 2026 · Marina Bay Sands, Singapore In 1938, Orson Welles stepped up to a radio microphone with no television, no internet, and no special effects beyond a few sound cues. He convinced millions of listeners that Martians were invading Earth. War of th Noel Ong Jun 25 11 min read Echo IQ – EchoSolv AS Enters Mount Sinai Health System Samso has been following the Echo IQ since September 2025. The research that went into preparing for the first Coffee with Samso with Dustin Haines was the eye opener for myself. It became very clear that this was a business that just needed validation and the first was the FDA submission which I now understand is not something that is caually done. The proecess and the acceptance of the request for approval in itself was a strenous process and is almost a tick of approval Noel Ong Apr 30 7 min read AI and The NVIDIAs AI Revolution – Why This Story Is Much Bigger Than a Chip Company. I started to look at the world in Artificial Intelligence (AI) seriously 12 months ago with a trip to the SuperAI Conference in Singapore in 2025, an event that I will be attending again this year on the 10th and 11th June 2026. As part of the AI revolution for the Samso Platform, I hunted for practitioners of the industry to get on a Coffee with Samso to just give us the "AI for Dummies" approach to start our journey into AI. Noel Ong Apr 27 13 min read Echo IQ – AI Diagnostics, Mayo Clinic & Hypergrowth This Coffee with Samso conversation with Dustin Haines from Echo IQ Limited (ASX: EIQ) reinforces a clear investment narrative: this is not just an AI story, but a data-driven healthcare business building a scalable diagnostic platform anchored in real clinical need. Noel Ong Apr 16 4 min read archTIS Awarded US/EU Alliance Contract, Provides DoD Update archTIS Limited (ASX: AR9) operates in a specialised segment of the cybersecurity market focused on data-centric security for government, defence, and regulated industries. The Company’s positioning within Zero Trust architecture and attribute-based access control (ABAC) environments places it in a sector where procurement cycles are long and compliance standards are strict. Noel Ong Mar 5 6 min read Adisyn Demonstrates 20dB Radar Signature Reduction with Graphene Samso has had a late entry to looking at looking at G11 Resources Limited (ASX: G11) as it explores for copper and gold within Tasmania’s Mt Read Volcanic Belt, a region that hosts the Mt Lyell Copper-Gold Mine and several other base metal and gold deposits. The Company’s focus is on structurally controlled mineralisation along the Great Lyell Fault, which is the main structural control to the Mt Lyell ore system. Noel Ong Mar 4 7 min read Adisyn Limited — A New Leader - A Semiconductor-Focused Business - - Is this Perfect Timing for New Investors? Adisyn Ltd (ASX: AI1) is advancing a graphene-based semiconductor technology platform through its wholly owned subsidiary, 2D Generation (2DG), supported by international research collaborations across Israel, Europe, and the United States. The Company’s core development work focuses on low-temperature graphene deposition processes designed for compatibility with existing semiconductor manufacturing environments. Noel Ong Feb 11 5 min read Adisyn Limited — Technical Validation, Strategic Focus, and Capital Reallocation - A Semiconductor Story Adisyn Ltd (ASX: AI1) is advancing a graphene-based semiconductor technology platform through its wholly owned subsidiary, 2D Generation (2DG), supported by international research collaborations across Israel, Europe, and the United States. The Company’s core development work focuses on low-temperature graphene deposition processes designed for compatibility with existing semiconductor manufacturing environments. Noel Ong Jan 13 6 min read archTIS Limited - U.S. Department of Defense Progress Signals Strategic Momentum - A Definte SamsoDYOR for Positioning Potential Upcoming Growth in Sales. archTIS Limited (ASX: AR9) has provided a detailed update on its progress with the United States Department of Defense (U.S. DoD), highlighting the successful production deployment of its NC Protect software within the Microsoft DoD365 environment. The update also outlines renewed licenses, customised development work, and new non-dilutive funding aimed at accelerating U.S. market penetration. The core activities are centred in the United States, with archTIS headquartered in Noel Ong Jan 8 6 min read 1 2 3 4 5

Samso Australia is committed to ensuring your personal information is professionally managed. Our privacy policy is to provide information to you on how your personal information is collected and used within Samso Australia, and the circumstances in which we share it with third parties. The Samso Editorial Charter Samso Australia | Editorial Charter 27th May 2026 How we decide what to publish, how to label it, and what to disclose This Samso Charter is the binding internal standard that governs every piece of content Samso publishes, regardless of how the work was funded. It is published in full so that readers, members, and prospective members can see exactly what we hold ourselves to — and so that anyone who finds Samso falling short can hold the published commitments up against the work. Preamble - What This Charter Is and Is Not The Samso Charter is binding. Every Samso piece — Coffee with Samso, Samso News, Samso Insights, Samso Amplification, and any future format — is produced to it. The standards apply equally to Independent Coverage (where the subject pays no fee) and to coverage produced for Samso Members. Where the Charter and any other agreement, expectation or convenience are in tension, the Charter wins. The Charter is not a guarantee of accuracy. We do our best. We will sometimes be wrong. When we are, we correct the record visibly and on the record — see the Corrections section below. The Charter is also not financial advice; nothing on the Samso platform is. We publish research and education. Investors are expected to do their own work. The Six Commitments 01. Disclosure Every Samso piece carries a label at the top stating how it came to exist. Independent Research means Samso chose the subject and no fee was paid by the subject. Samso Member — Essential, Samso Member — Growth, and Samso Member — Strategic mean the subject is a current member of the Samso Membership programme at that tier, and that the piece was produced under the editorial terms of that membership. The label is non-negotiable. A piece cannot be published without one. Readers always know which path produced what they are reading. The current register of members is at samso.com.au/disclosures and is referenced from every member-tier piece. 02. Membership buys access, not opinion Where a company joins the Samso Membership programme, the fee covers Samso’s research effort, the access required to deliver the work at depth, scheduling priority, and a place in the distribution footprint. It does not cover the conclusion. Risks are weighed, claims are checked, opinions remain Samso’s. Editorial control rests with Samso. Concretely: a member does not have approval rights over a piece’s framing, the questions asked, the risks named, or the conclusions drawn. A member has the right to review the piece for factual accuracy of objectively-verifiable claims (project specifications, dates, mineral grades, financial numbers as filed) before publication. A member does not have the right to require softening of editorial judgement or removal of risk discussion. If a member finds the Charter’s terms unworkable, the right course is not to join. We say this plainly during the first conversation. 03. Both sides addressed Every company review must address both the upside thesis and the principal risks. A piece that does only the upside is not Samso research, regardless of whether it carries the brand. The risks named will be the risks that materially affect the investment case — not boilerplate disclaimer language. What this looks like in practice: a Coffee with Samso about a single-asset exploration company should address grade and continuity risk, permitting, financing, and the realistic execution path — not just the deposit. A Samso Insights piece on a commodity bull case should address the demand assumptions, supply response, and the macro conditions that could invalidate the thesis. 04. Claims checked, not repeated Claims made in ASX announcements are framed, contextualised against the sector and the cycle, and questioned where they warrant questioning. Samso does not reproduce a press release. We read it, place it in context, and assess what it does and does not establish. For technical claims (geological, scientific, engineering), Samso draws on the founder’s thirty-plus years of geological practice and, where useful, brings in external specialists with named relevant expertise. For financial claims, we work from filed numbers — not derived investor presentations — and we are explicit about the difference. Where a claim is contested in the public record (analyst notes, regulator filings, prior history), we say so. 05. Holdings and exposures disclosed Where Samso, Noel Ong personally, or any close associate has a holding, exposure, or prior commercial relationship with a subject — current or historical — the disclosure is made at the top of the piece and is also recorded on the Disclosures page. ‘Holding’ is read broadly: equity, options, convertible notes, or any other security in the subject; founder, director or adviser positions held by Noel within the past three years; family-office or trust interests known to Samso. ‘Exposure’ includes commodity exposure where Samso is materially long or short a commodity that the subject’s project produces or consumes. When in doubt, we disclose. 06. Not financial advice Samso publishes research and education. Nothing on the Samso platform is, or should be construed as, personal financial advice. Investors are expected to do their own work, including taking advice from a licensed adviser appropriate to their circumstances. We provide depth, not direction. We will explain a thesis, weigh it against its risks, and tell you what we find compelling and what we find unresolved. We will not tell you to buy, sell, or hold. Editorial Disagreement Procedure Step 1: Pre-publication review for factual accuracy The member receives the piece in draft. They may flag any objectively-verifiable factual errors. Samso reviews each item and corrects what needs to be corrected. The member does not see editorial framing, questions or conclusions for approval — only the facts to be checked. Step 2: Editorial judgement remains with Samso If the disagreement is about framing, emphasis, the inclusion of a risk, or the substance of a conclusion, Samso’s judgement is final. The piece is published. The member may, if they wish, have a brief response statement noted in the piece or appended to it — clearly labelled as the member’s response. Step 3: If a member chooses to leave A member is free to terminate membership at any time. Termination does not retract published work — doing so would undermine the credibility of every piece on the platform. The member is moved from the active register to the historical register on the Disclosures page, dated. Reader Objections Reader objections to coverage are handled separately. A reader who believes a piece falls short of the Charter can raise it via the channels at the foot of this page. Reader objections that identify substantive Charter breaches are investigated; outcomes are recorded in the Corrections section. Corrections When Samso publishes something materially wrong — a factual error, a misattributed claim, a number that turns out to be incorrect, an interpretation that does not survive new information — we correct it visibly and on the record. Corrections are appended to the original piece, dated, and listed on a public Corrections page. Material errors are corrected within five business days of being identified. Non-material corrections (typos, minor wording) are made silently. The distinction is whether a reasonable reader’s understanding of the piece would change. Charter Version History This Charter is versioned. The current version is shown at the top of this page with its effective date. Material changes are listed in a public changelog below. ‘Material’ means any change to the six commitments, the editorial disagreement procedure, or the disclosure standards. Editorial copy-edits to the Charter that do not change substance are not versioned. Contact for Charter matters Reader objections, requests for clarification on how the Charter was applied to a specific piece, and proposed amendments can be sent directly to Noel: noel.ong@samso.com.au , subject line ‘Editorial Charter’. Contact Us Dsiclaimer

Pioneer Minerals Limited (ASX:PMM) Pioneer Minerals Limited (ASX: PMM) is a globally focused exploration company targeting critical minerals, with a strategic emphasis on uranium and lithium. The Company’s project portfolio spans key jurisdictions across Namibia, the United States, and Canada, positioning it to capitalise on growing demand for clean energy resources. Pioneer’s flagship Skull Creek Uranium Project in northwestern Colorado covers approximately 15.5 km² across 114 unpatented mining claims. I In southern Namibia, the Warmbad Uranium Project extends over 271 km² within the uranium-rich Namaqua Metamorphic Complex, a region recognised for its highly prospective granitic systems. In Canada, the Company holds the Root Lake Project, encompassing approximately 1,927 hectares in Ontario, located around 100 km north of Sioux Lookout and benefiting from excellent access via established road infrastructure. Additionally, the Benham Lithium Project in Ontario consists of 30 claims totalling approximately 1,245 hectares, strategically positioned along a fertile greenstone belt near the Ghost Lake Batholith—an area prospective for lithium-bearing pegmatites. Through its diversified asset base and focus on high-demand energy transition commodities, Pioneer Minerals Limited aims to deliver long-term value through discovery and development. Read More

Samso is an independent research media house producing depth-led video and written content on ASX-listed companies. We exist to create the research that helps listed businesses brand their story to investors who want to understand what matters. What Members Say About Samso Research Below: voices from ASX management teams who have been the subject of Samso research, and from readers who use Samso research as part of their own work. We publish both because both matter — what subjects say about being engaged at depth, and what readers say about the quality of the resulting work. From Management Teams Covered “Samso Media is a great platform to get our story across. It is always a pleasure sitting down with Noel. His passion for what he does is obvious, and I always appreciate an in-depth conversation with someone who puts in the background work to understand our business, the industry and the markets.” — Brad Valiukas, Managing Director, Kaiser Reef Limited (ASX: KAU) “Through Coffee with Samso, Noel Ong provides a thoughtful and balanced platform for companies like OD6 to communicate their story. His ability to translate complex technical concepts into clear, investor-focused insights — while maintaining an objective and measured view — sets Samso apart in a market often driven by short-term narratives.” — Brett Hazelden, Managing Director, OD6 Metals Limited (ASX: OD6) “Noel and the team are very professional and balanced. He always focuses the conversation on the important areas of business that matter most to investors. Noel has a great way of making the conversation relaxing yet educational.” — Dustin Haines, CEO, Echo IQ Limited (ASX: EIQ) Investors can make a well-rounded, informed decision with Blackstone Minerals Ltd (ASX:BSX) Client testimonial from Scott Williamson - Investors can make a well-rounded, informed decision with Blackstone Minerals Ltd (ASX:BSX) Apr 29, 2023 3 min read Poseidon Nickel Limited (ASX:POS) enjoys Samso's far-reaching and in-depth interviews Client testimonial from Peter Harold Poseidon Nickel Limited (ASX:POS) enjoys Samso's far-reaching and in-depth interviews Apr 29, 2023 3 min read Get deep insights into the mind of Warriedar Resources Limited (ASX: WA8) Client Testimonial from Amanda Buckingham, Warriedar Resources Limited (ASX: WA8) - an opportunity to discuss your project Apr 28, 2023 3 min read Mount Ridley Mines Limited (ASX: MRD) likes getting straight to what matters to investors Client testimonial from Guy Le Page -Mount Ridley Mines Limited (ASX: MRD) likes getting straight to what matters to investors Apr 27, 2023 4 min read An efficient interview style allows Cyprium Metals Limited (ASX:CYM) to fully explain the details Client testimonial from Barry Cahill - An efficient interview style allows Cyprium Metals Limited (ASX:CYM) to fully explain the details Apr 23, 2023 4 min read Drilling into details and a genuine interest in Cooper Metals Limited (ASX:CPM) Drilling into details and a genuine interest in Cooper Metals Limited (ASX:CPM) Client Testimonial from Ian Warland on Coffee With Samso Jun 6, 2022 2 min read Giving investors the opportunity to understand Venture Minerals Limited (ASX:VMS) well Client testimonial from Andrew Radonjic - Giving investors the opportunity to understand Venture Minerals Limited (ASX:VMS) well Jun 6, 2022 2 min read Samso's long-form format helps Critical Resources Limited (ASX:CRR) go in depth Client testimonial from Alex Biggs - Samso's long-form format helps Critical Resources Limited (ASX:CRR) go in depth Jun 6, 2022 2 min read Customising the experience for Tempest Minerals Limited (ASX:TEM) Client testimonial from Don Smith - Customising the experience for Tempest Minerals Limited (ASX:TEM) - authentic natural conversation Jun 6, 2022 2 min read 1 2 Testimonials